A tumor marker panel is a blood test measuring proteins that can be elevated in certain cancers, used as a supporting data point alongside imaging rather than a stand-alone diagnostic test. One draw covers the standard panel.
A single blood draw.
A laboratory test, not imaging.
Medione A. Basic Health Checkup, which lists CA19-9, AFP and CEA, with CA-125 added for women. (≈$373)
KMI STANDARD, which lists AFP and CEA in its blood panel at the same price. (≈$373)
One week is the earliest an imaging slot can be held, and there is no referral step before it.
English report in your hands in about a week. You also get a consultation on preliminary findings on the day of the screening, before you leave.
Programme contents and prices from each partner centre's own foreigner-facing published list, read 2026-08-05: KMI Global and Hanaro Medical Foundation's English site. Standalone per-test prices are a Korean partner centre's 비급여 (non-covered) posting, the itemised list 의료법 제45조 requires a clinic to publish, read the same day. Scheduling and report turnaround are Meridiko's own operating figures, confirmed 2026-08-06, not a centre's published ones (https://global.kmi.or.kr/examination/foreigner_examination; https://en-mobile.hanaromf.com/program/prog01/prog01_01.jsp), measured 2026-08-05. Dollar figures are converted from each centre's won price at ₩1,342 = $1 (open.er-api.com, 2026-09-13). The won figure is the price; the pairing moves with the rate.
Elevated levels of specific proteins associated with certain cancers, useful as a supporting signal alongside imaging and clinical history.
Tumor markers are neither sensitive nor specific enough to diagnose or exclude cancer on their own. A normal result does not rule out cancer, and an elevated one is not itself a diagnosis; both need to be read with your imaging and your own doctor.
Suits: Anyone undergoing a comprehensive screening who wants this data point recorded alongside their imaging results.
Should not have it: Anyone expecting a stand-alone answer from this test alone. It is not designed to be read that way, and no reputable clinic should present it as one.
Imaging (whole-body MRI, low-dose chest CT) looks for structural findings directly; a tumor marker panel is a blood chemistry signal that supports, but does not replace, imaging.
Every package this site prices includes a tumour-marker panel, at all four partner centres, so the band makes no difference to whether you get one. What differs is which markers, which is why the panel is worth reading by name. See /pricing/.
